CIPhotos / iStockphoto.com
Bristol-Myers Squibb (BMS) has taken AstraZeneca to court over the alleged infringement of a patent for cancer treatment.
Renew / upgrade subscription to view the page.
Bristol-Myers Squibb, BMS, AstraZeneca, patent, patent infringement, cancer, oncology,
